Reports of Blood Clots After AstraZeneca Vaccine Administration in Korea... Including 1 Death Case (Update)

On the afternoon of the 15th, medical staff demonstrated the preparation process of the AstraZeneca (AZ) vaccine at the COVID-19 vaccination center set up in the auditorium of Seongdong-gu Office in Seoul. Photo by Moon Honam munonam@

[Asia Economy Reporter Seo So-jung] For the first time in South Korea, a case of blood clot formation has been confirmed among people who died after receiving the AstraZeneca COVID-19 vaccine.

Jung Eun-kyung, Commissioner of the Korea Disease Control and Prevention Agency (KDCA), stated at the National Assembly Health and Welfare Committee plenary session on the 17th regarding blood clot formation after vaccination, "Currently, there are no reported cases of adverse reactions, but there is one death case with an autopsy report, and we plan to review that case."

The official autopsy results have not yet been reported.

According to the KDCA, the person reported to have developed blood clots after receiving the AstraZeneca vaccine is a woman in her 60s who was a patient hospitalized in a nursing hospital.

The KDCA said, "We are preparing to explain the related details at this afternoon's back briefing."

This content was produced with the assistance of AI translation services.